[go: up one dir, main page]

GB201517527D0 - GDF-15 as a diagnosis marker to predict the clinical outcome of a treatment with immune checkpoint blockers - Google Patents

GDF-15 as a diagnosis marker to predict the clinical outcome of a treatment with immune checkpoint blockers

Info

Publication number
GB201517527D0
GB201517527D0 GBGB1517527.6A GB201517527A GB201517527D0 GB 201517527 D0 GB201517527 D0 GB 201517527D0 GB 201517527 A GB201517527 A GB 201517527A GB 201517527 D0 GB201517527 D0 GB 201517527D0
Authority
GB
United Kingdom
Prior art keywords
gdf
predict
treatment
immune checkpoint
clinical outcome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1517527.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Julius Maximilians Universitaet Wuerzburg
Original Assignee
Julius Maximilians Universitaet Wuerzburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Julius Maximilians Universitaet Wuerzburg filed Critical Julius Maximilians Universitaet Wuerzburg
Priority to GBGB1517527.6A priority Critical patent/GB201517527D0/en
Publication of GB201517527D0 publication Critical patent/GB201517527D0/en
Priority to ES16779036T priority patent/ES2968226T3/en
Priority to EP16779036.9A priority patent/EP3356827B1/en
Priority to DK16779036.9T priority patent/DK3356827T3/en
Priority to CA3000290A priority patent/CA3000290C/en
Priority to AU2016333538A priority patent/AU2016333538B2/en
Priority to US15/765,174 priority patent/US11262360B2/en
Priority to PCT/EP2016/073519 priority patent/WO2017055612A1/en
Priority to JP2018516740A priority patent/JP6858181B2/en
Priority to EP23206060.8A priority patent/EP4321866A3/en
Priority to KR1020187012419A priority patent/KR102621034B1/en
Priority to FIEP16779036.9T priority patent/FI3356827T3/en
Priority to US17/580,245 priority patent/US12473354B2/en
Ceased legal-status Critical Current

Links

GBGB1517527.6A 2015-10-02 2015-10-02 GDF-15 as a diagnosis marker to predict the clinical outcome of a treatment with immune checkpoint blockers Ceased GB201517527D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GBGB1517527.6A GB201517527D0 (en) 2015-10-02 2015-10-02 GDF-15 as a diagnosis marker to predict the clinical outcome of a treatment with immune checkpoint blockers
FIEP16779036.9T FI3356827T3 (en) 2015-10-02 2016-09-30 Gdf-15 as a diagnostic marker to predict the clinical outcome of a treatment with immune checkpoint blockers
US15/765,174 US11262360B2 (en) 2015-10-02 2016-09-30 GDF-15 as a diagnostic marker to predict the clinical outcome of a treatment with immune checkpoint blockers
EP16779036.9A EP3356827B1 (en) 2015-10-02 2016-09-30 Gdf-15 as a diagnostic marker to predict the clinical outcome of a treatment with immune checkpoint blockers
DK16779036.9T DK3356827T3 (en) 2015-10-02 2016-09-30 GDF-15 AS A DIAGNOSTIC MARKER FOR PREDICTING THE CLINICAL OUTCOME OF TREATMENT WITH IMMUNE CHECKPOINT BLOCKERS
CA3000290A CA3000290C (en) 2015-10-02 2016-09-30 Gdf-15 as a diagnostic marker to predict the clinical outcome of a treatment with immune checkpoint blockers
AU2016333538A AU2016333538B2 (en) 2015-10-02 2016-09-30 GDF-15 as a diagnostic marker to predict the clinical outcome of a treatment with immune checkpoint blockers
ES16779036T ES2968226T3 (en) 2015-10-02 2016-09-30 GDF-15 as a diagnostic marker to predict the clinical outcome of treatment with immune checkpoint blockers
PCT/EP2016/073519 WO2017055612A1 (en) 2015-10-02 2016-09-30 Gdf-15 as a diagnostic marker to predict the clinical outcome of a treatment with immune checkpoint blockers
JP2018516740A JP6858181B2 (en) 2015-10-02 2016-09-30 GDF-15 as a diagnostic marker for predicting clinical outcomes of treatment with immune checkpoint blockers
EP23206060.8A EP4321866A3 (en) 2015-10-02 2016-09-30 Gdf-15 as a diagnostic marker to predict the clinical outcome of a treatment with immune checkpoint blockers
KR1020187012419A KR102621034B1 (en) 2015-10-02 2016-09-30 GDF-15 as a diagnostic marker to predict the clinical course of treatment with immune checkpoint blockers
US17/580,245 US12473354B2 (en) 2015-10-02 2022-01-20 GDF-15 as a diagnostic marker to predict the clinical outcome of a treatment with immune checkpoint blockers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1517527.6A GB201517527D0 (en) 2015-10-02 2015-10-02 GDF-15 as a diagnosis marker to predict the clinical outcome of a treatment with immune checkpoint blockers

Publications (1)

Publication Number Publication Date
GB201517527D0 true GB201517527D0 (en) 2015-11-18

Family

ID=54606072

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1517527.6A Ceased GB201517527D0 (en) 2015-10-02 2015-10-02 GDF-15 as a diagnosis marker to predict the clinical outcome of a treatment with immune checkpoint blockers

Country Status (1)

Country Link
GB (1) GB201517527D0 (en)

Similar Documents

Publication Publication Date Title
DK3356827T3 (en) GDF-15 AS A DIAGNOSTIC MARKER FOR PREDICTING THE CLINICAL OUTCOME OF TREATMENT WITH IMMUNE CHECKPOINT BLOCKERS
LT3556775T (en) ANTI-LAG-3 ANTIBODIES FOR THE TREATMENT OF HAEMATOLOGICAL MALICULAR DISEASES
IL262522B (en) Therapeutic neuregulin peptides for the treatment or prophylaxis of heart failure
SI3777772T1 (en) Prosthetic heart valve
EP2960362A4 (en) Shoes upper part knitting method
IL240769A0 (en) Human antibodies to grem 1
AU359728S (en) Exercise garments with integrated legwarmers
SI3998070T1 (en) Mir-124 as a biomarker for the treatment of inflammatory diseases
IL243682A0 (en) Cyclic polypeptides for the treatment of heart failure
IL244042A0 (en) Method for the treatment of fibrotic disease
EP2892548A4 (en) COMBINATIONS OF MODALITIES FOR THE TREATMENT OF DIABETES
IL255046A0 (en) Biosequence-based approach to analyzing binaries
SI3102949T1 (en) Diagnosis of a neurological disease
SG11201606322XA (en) Novel assay to detect human periostin
IL259704A (en) Ccl20 as a predictor of clinical response to il23-antagonists
EP2990010A4 (en) Artificial blood vessel
IL248592A0 (en) Treatment of crohn's disease with delayed-release 6-mercaptopurine
GB2540970B (en) Executing Groups of Instructions Atomically
GB201408621D0 (en) Apparatus for traking the position of at least one person walking about a structure
IL252528A0 (en) Assay to detect human dpp-4
GB201517527D0 (en) GDF-15 as a diagnosis marker to predict the clinical outcome of a treatment with immune checkpoint blockers
GB201607800D0 (en) GDF-15 as a diagnostic marker to predict the clinical outcome of a treatment with immune checkpoint blockers
ES2405838B8 (en) Last for the structural maintenance of the body of a shoe
GB201410118D0 (en) Early diagnosis of leptospire
GB201419896D0 (en) Improvements relating to human body measurement

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)